ICU Medical (ICUI) FY2013 results: revenue $314 million, down 1.0% on the year
ICU Medical Inc. (ICUI) reported revenue of $314 million for fiscal 2013, the year ended 31 December 2013, down 1.0% on the year before. Net income was $40 million, down 2.1%, and diluted earnings per share $2.65. The figures are the company's own, from the 10-K it filed with the SEC on 21 February 2014.
Revenue
$314 million
-1.0% on the year
FY2007FY2013
Operating margin
16.6%
19.3% a year earlier
FY2007FY2013
Net income
$40 million
-2.1% on the year
FY2007FY2013
Diluted EPS
$2.65
-5.4% on the year
FY2007FY2013
this yearthe year beforeHover a bar for its figure.
The year in brief
Income statement (profit and loss)
$ million
FY2013
FY2012
FY2011
On the year
Last 8 years
Revenue
314
317
302
-1.0%
Cost of revenue
159
160
160
-0.9%
Gross profit
155
157
142
-1.1%
Gross margin
49.3%
49.4%
47.1%
Research and development
12.4
10.6
8.6
+16.7%
Selling, general and administrative
89.0
84.6
85.3
+5.2%
Operating income
51.9
61.3
65.2
-15.2%
Operating margin
16.6%
19.3%
21.6%
Pre-tax income
52.7
61.8
66.4
-14.8%
Income tax
12.3
20.6
21.8
-40.2%
Effective tax rate
23.3%
33.2%
32.7%
Net income
40.4
41.3
44.7
-2.1%
Net margin
12.9%
13.0%
14.8%
Diluted EPS
$2.65
$2.80
$3.15
-5.4%
$ million except per share. Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.
Cash flow
$ million
FY2013
FY2012
FY2011
On the year
Last 8 years
Operating cash flow
65.7
66.3
64.5
-0.8%
Capital expenditure
18.4
19.2
15.8
-3.9%
Free cash flow
47.3
47.1
48.7
+0.4%
Free cash flow margin
15.1%
14.9%
16.1%
Cash from investing
-13.1
-41.4
-45.7
Cash from financing
24.4
21.6
2.1
+12.8%
Depreciation and amortisation
19.5
19.0
18.3
+2.7%
Share-based compensation
5.4
5.6
4.0
-2.3%
Buybacks
3.0
0.0
12.0
Diluted shares, weighted
15m
15m
14m
+3.7%
Shares outstanding at period end
15m
14m
14m
+4.5%
Balance sheet
$ million
FY2013
FY2012
FY2011
On the year
Last 8 years
Shareholders' equity
465
391
321
+18.9%
Debt
0.0
0.0
0.0
Other liabilities
34.9
37.7
40.5
-7.3%
Total liabilities and equity
500
429
361
+16.6%
Fixed assets
87.9
85.9
85.9
+2.2%
Goodwill
1.5
1.5
1.5
0.0%
Intangible assets
8.5
10.0
11.4
-14.7%
Investments
70.9
79.3
60.4
-10.6%
Cash and equivalents
226
147
99.6
+53.9%
Receivables
45.3
49.1
43.6
-7.8%
Inventory
34.5
36.3
40.4
-5.2%
Other assets
25.2
19.5
18.3
+28.8%
Total assets
500
429
361
+16.6%
10-K for the year ended 31 December 2013, filed 21 February 2014: the filing.